Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,072 public trials 579 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Active, Not Recruiting

Loncastuximab Tesirine in WM

NCT05190705

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Fred Hutch Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

NCT04649359

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UCLA Hematology/Oncology Clinic Los Angeles, California, United States
  • UC Irvine Health - Chao Family Comprehensive Cancer Center Orange, California, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

NCT05354557

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Followup) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent and Follow up) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone

NCT03104842

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Vivantes Am Urban Berlin, Germany
  • Campus Benjamin Franklin Charite Berlin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
  • Städt. Kliniken Bielefeld Klinikum Mitte Bielefeld, Germany
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma

NCT05646836

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
  • Sygehus Lillebaelt - Vejle Sygehus Vejle, Denmark
View all 13 locations
View Trial Details

Related conditions